Back
Xenon Pharmaceuticals, Inc. 10K Form
Buy
54
XENE
Xenon Pharmaceuticals, Inc.
Last Price:
$44.58
Seasonality Move:
19.83%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | XENE/Xenon Pharmaceuticals, Inc. Quarterly |
| 2023-11-08 | 10Q | XENE/Xenon Pharmaceuticals, Inc. Quarterly |
| 2023-08-09 | 10Q | XENE/Xenon Pharmaceuticals, Inc. Quarterly |
| 2023-05-09 | 10Q | XENE/Xenon Pharmaceuticals, Inc. Quarterly |
| 2022-11-08 | 10Q | XENE/Xenon Pharmaceuticals, Inc. Quarterly |
| 2022-08-09 | 10Q | XENE/Xenon Pharmaceuticals, Inc. Quarterly |
Receive XENE News And Ratings
See the #1 stock for the next 7 days that we like better than XENE
XENE Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-72.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $7.26 |
| Price / Book: | 6.16 |
Profitability
| EPS (TTM): | -3.88450 |
|---|---|
| Net Income (TTM): | $-306.3M |
| Gross Margin: | $-2.6M |
| Return on Equity: | -44.39% |
| Return on Assets: | -38.99% |
Xenon Pharmaceuticals, Inc. Earnings Forecast
Key Xenon Pharmaceuticals, Inc. Financial Ratios
-
Per Share Earnings over the last 14 years have been positive in 6 years.
Xenon Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | XENE |
| CUSIP: | 98420N |
| Website: | xenon-pharma.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 12.52 |
| Quick Ratio: | 12.08 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
XENE Technical Analysis vs Fundamental Analysis
Buy
54
Xenon Pharmaceuticals, Inc. (XENE)
is a Buy
Is Xenon Pharmaceuticals, Inc. a Buy or a Sell?
-
Xenon Pharmaceuticals, Inc. stock is rated a BuyThe current Xenon Pharmaceuticals, Inc. [XENE] share price is $44.61. The Score for XENE is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.